Furthermore, MACC1 alone or in conjunction with FN1 might serve as a novel biomarker for PC prognosis and targeting the MACC1-SNAI1 complex might represent a promising method for PC metastasis. This evidence concerns the gene FN1 and pachyonychia congenita.